Then, we confirm that nanoliposomes distribute to M2-TAMs in vivo and delivery of different compounds (STAT6 inhibitor (AS1517499), zoledronic acid or muramyl tripeptide) reduces the premetastatic niche and/or tumor growth in vivo. This evidence concerns the gene STAT6 and neoplasm.